ChadLDealMD

PubMed

• Correction: Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults.
  Aliya A Khan, Maria Luisa Brandi, Eric T Rush, Dalal S Ali, Hatim Al-Alwani, Khulod Almonaei, Farah Alsarraf, Severine Bacrot, Kathryn M Dahir, Karel Dandurand, Chad D...> ;Osteoporosis International. 2024 Mar 18
• Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults.
  Aliya A Khan, Maria Luisa Brandi, Eric T Rush, Dalal S Ali, Hatim Al-Alwani, Khulod Almonaei, Farah Alsarraf, Severine Bacrot, Kathryn M Dahir, Karel Dandurand, Chad D...> ;Osteoporosis International. 2024 Mar 1
• Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group.
  Eric Rush, Maria Luisa Brandi, Aliya Khan, Dalal S Ali, Hatim Al-Alwani, Khulod Almonaei, Farah Alsarraf, Severine Bacrot, Kathryn M Dahir, Karel Dandurand, Chad Deal,...> ;Osteoporosis International. 2024 Jan 1
• 1 citations
  The challenge of hypophosphatasia diagnosis in adults: results from the HPP International Working Group Literature Surveillance.
  Maria Luisa Brandi, Aliya A Khan, Eric T Rush, Dalal S Ali, Hatim Al-Alwani, Khulod Almonaei, Farah Alsarraf, Severine Bacrot, Kathryn M Dahir, Karel Dandurand, Chad D...> ;Osteoporosis International. 2024 Mar 1
• 2 citations
  Hydroxychloroquine prescription practices after 2016 AAO recommendations
  Rebecca I. Chen, Andrew X. Chen, Tyler E. Greenlee, Thais F. Conti, Chad L. Deal, Rishi P Singh> ;Ophthalmology. 2021 Mar 16
• 3 citations
  Abaloparatide Real-World Patient Experience Study.
  Deborah T. Gold, Rick Weiss, Tammy Beckett, Chad L. Deal, Robert S Epstein, Andrew L James, Jacqueline M Kernaghan, Mahshid Mohseni, Michael Spiegel, Tamara Vokes, Jen...> ;JBMR Plus. 2021 Mar 1
• 9 citations
  Patient-reported experience with patient-reported outcome measures in adult patients seen in rheumatology clinics.
  Brittany Lapin, Ryan D. Honomichl, Nicolas R. Thompson, Susannah L. Rose, Abby Abelson, Chad L. Deal, Irene L. Katzan> ;Quality of Life Research. 2021 Apr 1
• 4 citations
  Abaloparatide followed by alendronate in women ≥80 years with osteoporosis: post hoc analysis of ACTIVExtend.
  Susan L. Greenspan, Lorraine A. Fitzpatrick, Bruce H. Mitlak, Yamei Wang, Nicholas C. Harvey, Chad L. Deal, Felicia Cosman, Michael R. McClung> ;Menopause. 2020 Oct 1
• 1 citations
  The influence of collecting patient-reported outcome measures on visit satisfaction in rheumatology clinics.
  Ryan D. Honomichl, Irene L. Katzan, Nicolas R. Thompson, Abby Abelson, Chad L. Deal, Susannah L. Rose, Brittany Lapin> ;Rheumatology Advances in Practice. 2020 Sep 1
• Denosumab cessation.
  Chad L Deal> ;Cleveland Clinic Journal of Medicine. 2020 Jun 1
• 4 citations
  Response rates for hip, femoral neck, and lumbar spine bone mineral density in patients treated with abaloparatide followed by alendronate: Results from phase 3 ACTIVE...
  Chad L. Deal, Bruce H. Mitlak, Yamei Wang, Lorraine A. Fitzpatrick, Paul D. Miller> ;Bone Reports. 2019 Nov 2
• 267 citations
  2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis
  Jasvinder A. Singh, Gordon H. Guyatt, Alexis Ogdie, Dafna D. Gladman, Chad L. Deal, Atul Deodhar, Maureen Dubreuil, Jonathan Dunham, M. Elaine Husni, Sarah Kenny, Jenn...> ;Arthritis & Rheumatology. 2019 Jan 1
• 137 citations
  Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.
  Jasvinder A Singh, Gordon Guyatt, Alexis Ogdie, Dafna D Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan Dunham, M Elaine Husni, Sarah Kenny, Jennifer Kwan...> ;Arthritis Care & Research. 2019 Jan 1
• 15 citations
  2015 American College of Rheumatology Workforce Study
  Marcy B. Bolster, Anne R. Bass, Jonathan S. Hausmann, Chad L. Deal, Marcia Ditmyer, Kamilah L. Greene, Seetha U. Monrad, Daniel F. Battafarano> ;Arthritis & Rheumatology. 2018 Jun 1
• 147 citations
  2015 American College of Rheumatology Workforce Study: Supply and Demand Projections of Adult Rheumatology Workforce, 2015-2030.
  Daniel F. Battafarano, Marcia Ditmyer, Marcy B. Bolster, John FitzGerald, Chad L. Deal, Ann R. Bass, Rodolfo Molina, Alan R Erickson, Jonathan S. Hausmann, Marisa S. K...> ;Arthritis Care & Research. 2018 Apr 1
• 11 citations
  2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis: Comment on the Article by Buckley et al.
  Michael Maricic, Chad L. Deal, Robin Dore, Andrew Laster> ;Arthritis Care & Research. 2018 Jun 1
• Left clavicular fracture. Pyknodysostosis.
  Lulu He, Carl S. Winalski, Chad L. Deal, Darlene Holden> ;Skeletal Radiology. 2016 Jun 1
• 22 citations
  DXA Utilization Between 2006 and 2012 in Commercially Insured Younger Postmenopausal Women.
  Robert A. Overman, Joel F. Farley, Jeffrey R. Curtis, Jie Zhang, Margaret L. Gourlay, Chad L. Deal> ;Journal of Clinical Densitometry. 2015 Apr 1
• 16 citations
  Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis
  Robert A. Overman, Margaret L. Gourlay, Chad L. Deal, Joel F. Farley, MA Brookhart, James Bradley Layton> ;Osteoporosis International. 2015 Jan 20
• 24 citations
  United States Adults Meeting 2010 American College of Rheumatology Criteria for Treatment and Prevention of Glucocorticoid‐Induced Osteoporosis
  Robert A. Overman, Joshua C. Toliver, Jun Yen Yeh, Margaret L. Gourlay, Chad L. Deal> ;Arthritis Care & Research. 2014 Nov 1
• 4 citations
  Editorial: The Regional Distribution of Rheumatologists: What Can We Do, What Should We Do?
  Chad L. Deal> ;Arthritis and Rheumatism. 2013 Dec 1
• 57 citations
  The Official Positions of the International Society for Clinical Densitometry: Vertebral Fracture Assessment
  Harold N. Rosen, Tamara Vokes, Alan O. Malabanan, Chad L. Deal, Jimmy D. Alele, Thomas P. Olenginski, John T. Schousboe> ;Journal of Clinical Densitometry. 2013 Oct 1
• 14 citations
  Indications of DXA in women younger than 65 yr and men younger than 70 yr: the 2013 Official Positions.
  Alan O. Malabanan, Harold N. Rosen, Tamara Vokes, Chad L. Deal, Jimmy D. Alele, Thomas P. Olenginski, John T. Schousboe> ;Journal of Clinical Densitometry. 2013 Oct 1
• 252 citations
  Prevalence of oral glucocorticoid usage in the United States: a general population perspective.
  Robert A. Overman, Jun Yen Yeh, Chad L. Deal> ;Arthritis Care & Research. 2013 Feb 1
• 9 citations
  Recent recommendations on steroid-induced osteoporosis: More targeted, but more complicated
  Chad L. Deal> ;Cleveland Clinic Journal of Medicine. 2013 Feb 1
• Join now to see all

Journal Articles

• Left clavicular fracture  
  He L, Winalski CS, Deal C, Holden D, Skeletal Radiol, 1/1/2016
• Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis  
  Overman RA, Gourlay ML, Deal CL, Farley JF, Brookhart MA, Layton JB., Osteoporos Int., 1/1/2015
• DXA utilization between 2006 and 2012 in commercially insured younger postmenopausal women  
  Overman RA, Farley JF, Curtis JR, Zhang J, Gourlay ML, Deal CL, J Clin Densitometry, 1/1/2015
• United States adults meeting 2010 American College of Rheumatology criteria for treatment and prevention of glucocorticoid-induced osteoporosis  
  Overman R, Toliver JC, Gourlay ML, Deal CL, Arthritis Rheumatol, 1/1/2014
• Recent recommendations on steroid-induced osteoporosis: More targeted, but more complicated  
  Deal C, Clev Clinic J Med, 1/1/2013
• Prevalence of oral glucocorticoid usage in the United States: A general population perspective  
  Overman RA, Jun-Yen Y, Deal C, Arthritis Care Res, 1/1/2013
• The official positions of the International Society for Clinical Densitometry: Vertebral Fracture Assessment  
  Rosen H, Vokes T, Malabanan A, Deal C, et al., J Clin Densitom, 1/1/2013
• Indications of DXA in Women Younger than 65 yr and Men Younger than 70 yr  
  Malabanan A, Rosen H, Vokes T, Deal C, et al., The 2013 Official Positions, 1/1/2013
• The Regional Distribution of Rheumatologists: What Can We Do, What Should We Do  
  Deal C, Arthritis Rheum, 1/1/2013
• Bone Loss in rheumatoid arthritis: Systemic, periarticular and focal  
  Deal C, Curr Rheumatol Rep, 1/1/2012
• Emerging therapies for osteoporosis  
  Deal C, Rheum Dis Clin N Am, 1/1/2011
• A 21-year-old man with Still’s Disease with fever, rash and pancytopenia  
  Mehta B, Hashkes P, Avery R, Deal C, Arthritis Care Res, 1/1/2010
• American College of Rheumatology 2010 Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis  
  Grossman J, Gordon R, Ranganath VK, Deal C, et al., Arthritis Care Res, 1/1/2010
• Potential new drug targets for osteoporosis  
  Deal C, Nature Clinical Practice Rheumatology, 1/1/2009
• Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: A randomized blinded,...  
  Brown J, Prince R, Deal C, et al., J Bone Miner Res, 1/1/2009
• Absolute fracture risk  
  Deal C, Current Rheumatology Reports, 1/1/2007
• Raloxifene: a selective estrogen-receptor modulator for postmenopausal osteoporosis - a clinical update on efficacy and safety  
  Deal C, Draper MW, Women’s Health, 1/1/2006
• Successes and failures in improving osteoporosis care after fragility fracture : results of a multi-site clinical improvement project  
  Harrington T, Deal C, Arthritis Rheum (Arthritis Care & Research), 1/1/2006
• Secondary osteoporosis: are we recognizing it?  
  Sikon A, Thacker H, Carey J, Deal C, Licata A, Journal Women’s Health, 1/1/2006
• Combination therapy: rethinking the paradigm  
  Deal C, Osteoporosis Today, 1/1/2006
• Combination therapy with antiresorptive and anabolic agents  
  Deal C, Clinical Reviews in Bone and Mineral Metabolism, 1/1/2006
• Osteoporosis therapies: Bisphosphonates, SERMs, PTH, and new therapies  
  Deal CL, Clinical Reviews in Bone and Mineral Metabolism, 1/1/2005
• The use of intermittent human parathyroid hormone as a treatment for osteoporosis  
  Deal CL, Current Rheumatology Reports, 1/1/2004
• Clinical use of teriparatide in the real world: Initial insights  
  Miller PD, Bilezikian JP, Deal C, et al., Endocrine Practice, 1/1/2004
• Glucocorticocoids and fracture risk  
  Deal CL, Osteoporosis Today, 1/1/2004
• Join now to see all

Books/Book Chapters

• Rheumatology 
  Chapter: Chapter 201: Management of Osteoporosis 
  Deal C, Abelson AEditors: Hochberg M, et al.Mosby2014
• Rheumatology 
  Chapter: Chapter 190: Management of Osteoporosis 
  Deal C, Abelson A, CareyEditors: Hochberg M, et al.Mosby2007
• Bone Disease in Rheumatology 
  Chapter: Use of bisphosphonates in rheumatic disease and osteoporosis 
  Deal CLEditors: Gluck O, Maricic M.Lippincott, Williams and Wilkins2005
• Current Geriatric Diagnosis and Treatment 
  Chapter: Osteoporosis and hip fractures 
  Srivastava M, Deal CEditors: Palmer R.Lange Medical Books2004
• Diagnostic Procedures Handbook 
  Chapter: Bone density 
  Deal CLEditors: Michota FA.Lexi-Comp, Inc., Hudson, OH2001
• Neuromuscular Disorders in Clinical Practice 
  Chapter: Chapter 85: Polymyalgia Rheumatica 
  Deal CLEditors: Katirji B, et al.Butterworth Heinemann, Boston2001
• Serving Minority Elders in the 21st Century 
  Chapter: Osteoporosis Overview--Should minorities be concerned? 
  Deal CLEditors: Wykle ML, Ford AB.Springer, New York, N.Y.1999
• Oxford Textbook of Rheumatology 
  Chapter: Endocrinology in the rheumatic diseases 
  Deal CLEditors: Maddison PJ, et al.Oxford University Press1993
• Clinical Problems in Acute Care Medicine 
  Chapter: Acute presentations of common rheumatic problems, anaphylaxis, angioedema 
  Deal CLEditors: Hefferman JJ, Witzburg RA, Cohen AS.W.B. Saunders Company1989
• C-reactive Protein and the Plasma Protein Response to Tissue Injury 
  Chapter: The effect of amyloid enhancing factor (AEF) on the acute phase serum amyloid A (SAA) and serum amyloid P (SAP) response to silver nitrate 
  Deal CL, Sipe JD, Skinner M, Tatsuta E, Cohen ASEditors: Kushner I, Volanakis JE Gerwurz H.New York Academy of Sciences, New York1982
• Join now to see all

Abstracts/Posters

• Health Utility following osteoporotic fracture using SF6D: Results form ICUROS US
  Silverman S, Gold DT, Schousboe JT, Deal CL, et al., J Bone Miner Res, 1/1/2015
• Anti-Osteoporosis medication use after hip or vertebral fracture
  Overman RA, Deal CL, Arthritis Rheumatol, 1/1/2014
• Continued zoledronic acid use in a large healthcare system
  Overman RA, Lauffenburger JC, Gourlay ML, Deal CL, Arthritis Rheumatol, 1/1/2014
• Adherence to denosumab in a large healthcare system
  Overman RA, Lauffenburger JC, Gourlay ML, Deal CL, Arthritis Rheumatol, 1/1/2014
• Proportion of US older adults meeting inclusion criteria for 2010 ACR Recommendations on Glucocorticoid-Induced-Osteoporosis
  Overman R, Toliver J, Yeh JY, Gourlay M, Deal C, Arthritis and Rheumatism, 1/1/2013
• Evaluation of osteoporosis starts in patients based on T-score and FRAX® absolute fracture risk model in a large health care system
  Overman R, Deal C, Arthritis and Rheumatism, 1/1/2013
• Use of Uric Lowering Therapies within a Large Health Care System
  Overman, R, Deal, C, Mandell B, Arthritis & Rheumatism, 1/1/2012
• Treatment of bacterial overgrowth and vitamin D levels
  Williams S, Licata A, Deal C, Endocrine Reviews, 1/1/2010
• Zoledronic acid prevents accelerated bone loss after discontinuation of teriparatide
  Deal C, Tuthill K, Kreigman A, J Bone Miner Res, 1/1/2008
• Effect of denosumab vs alendronate on bone turnover markers and bone density changes at 12 months based on baseline bone turnover level
  Brown J, Deal C, Gregorio LH, Hofbauer LC, Wang H, Austin M, Wagman RB, Newmark R, Libanati C, San Martin J, J Bone Miner Res, 1/1/2008
• BMD response to teriparatide in patients previously treated with a bisphosphonate versus treatment naïve patients
  File EA, Deal C, Arthritis Rheum, 1/1/2007
• US rheumatology supply and demand : 2005-2006 workforce study
  Deal C, Barr W, Harrington T, et al., Arthritis Rheum, 1/1/2006
• Characteristics of rheumatology practices that employ physician assistants and nurse practitioners : Findings of the American College of Rheumatology subcommittee on w...
  Hooker R, Deal C, Barr W, et al., Arthritis Rheum, 1/1/2006
• Outcome after formal recommendation to evaluate for secondary causes of low bone mass on the bone mineral density report
  Carey J, Delaney M, Licata A, Deal C, et al., Arthritis Rheum, 1/1/2005
• Adult hypophosphatasia treated with Teriparatide
  Deal C, Whyte MP, J Bone Min Res, 1/1/2005
• Concomitant teriparatide plus raloxifene for the treatment of postmenopausal osteoporosis: results from a randomized placebo-controlled trial
  Deal C, Omizo M, Schwartz E, et al., Arthritis Rheum, 1/1/2004
• Raloxifene in combination with teriparatide reduces teriparatide-induced stimulation of bone resorption but not formation in postmentopausal women with osteoporosis
  Deal C, Omizo M, Schwartz E, et al., J Bone Min Res, 1/1/2004
• Calcaneal ultrasound-influence of activity and comparison with standard Dexa measurements in general clinical practice
  Danese RD, Licata AP, Richmond B, Deal C, Osteoporosis Int, 1/1/2000
• A psychosocial program to decrease the risk of osteoporosis
  Kwoh CK, Deal CL, Moskowitz RW, Arthritis Rheum, 1/1/1998
• Factors influencing vertebral bone density after renal transplantation
  Wolpaw TM, Deal CL, Schulak JA, Hricik DE, J Am Soc Nephrol, 1/1/1993
• Treatment of osteoarthritis of the knee with pulsed electrical stimulation
  Deal CL, Zizic TM. Hoffman TC, Holt PA, Hungerford TS, Arthritis Rheum, 1/1/1993
• Changes in bone and body composition with high dose corticosteroids over three months
  Deal CL, Eberle RW, Mazess RB, Barden H, Journal of Bone and Mineral Research, 1/1/1992
• Bone loss in patients treated with high dose corticosteroids
  Deal CL, Eberle RW, Mazess RB, Barden H, Arthritis Rheum, 1/1/1992
• Changes in total body composition with high dose corticosteroids
  Deal CL, Eberle RW, Mazess RB, Barden H, Arthritis Rheum, 1/1/1992
• DEXA measurement of peri-prosthetic bone mineral density in total hip arthroplasty
  Richmond BJ, Eberle RW, Stulberg BN, Deal CL, 8th International Workshop on Bone Densitometry, Bad Reichenhall, Germany, 1/29/1991
• Join now to see all

Lectures

• Essentials for the Spine Care Clinician 
  Cleveland Clinic - Cleveland, Ohio / The Cleveland Clinic Foundation, Cleveland, Ohio - 11/3/2012
• Nephrology Update 2012 
  Cleveland Clinic - Cleveland, Ohio / The Cleveland Clinic Foundation, Cleveland, Ohio - 9/27/2012